38850-18-9 Usage
General Description
The chemical (8Z,24E)-8-{[(hexyloxy)amino]methylidene}-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a complex organic compound with a long molecular structure. It contains a combination of hydroxy, methoxy, and acetate functional groups, as well as a hexyloxyamino side chain. The molecule also features a naphthofuran core and an epoxypentadeca[1,11,13]trienoimino side chain. (8Z,24E)-8-{[(hexyloxy)amino]methylidene}-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate likely possesses a variety of chemical and biological properties due to its intricate structure, but further research would be needed to fully understand its potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 38850-18-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,8,5 and 0 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 38850-18:
(7*3)+(6*8)+(5*8)+(4*5)+(3*0)+(2*1)+(1*8)=139
139 % 10 = 9
So 38850-18-9 is a valid CAS Registry Number.
38850-18-9Relevant articles and documents
Oximes of 3 formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties
Cricchio,Lancini,Tamborini,Sensi
, p. 396 - 403 (2007/10/06)
The synthesis of the oximes of 3 formylrifamycin SV and the preparation of some of the O substituted hydroxylamine intermediates are described. The chemical and physical characteristics, the antibacterial activity on wild type and rifampicin resistant strains, and other biological properties of the new derivatives are reported. Structure activity relationships show that increasing the lipophilicity of the oxime substituent decreases the antibacterial activity, both in vitro and in experimental infection, whereas inhibition of a rifampicin resistant strain of S. aureus and of several transcribing enzymes is increased.
